Floatz logo

Levoleucovorin

Metastatic Cancer

Federation Francophone de Cancerologie DigestivePhase 3Dormant
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
55/ 100
Competitive Position
73/ 100

Competitive context

141 Active assets in the Metastatic Cancer cohort.

Asset / SponsorPhaseRating
(+)-VINCRISTINE
Incyte Corporation
Phase 2/3BB
FLUOROURACILUM
I-Mab Biopharma US Limited
Phase 3BB
Calcium folinate pentahydrate
I-Mab Biopharma US Limited
Phase 3BB
Irinotecan
Incyte Corporation
Phase 3BB
FILGRASTIM
Mayo Clinic
Phase 3BB

View all 50 →

Same molecule, other indications

Levoleucovorin is also rated in:

gastroesophageal junction adenocarcinomaDormant
BB
Indicative ·
68 / 100
View asset →
Advanced/Metastatic Gastroesophageal AdenocarcinomaDormant
BB
Indicative ·
68 / 100
View asset →
colorectal cancerDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →